ILCN.org (ILCN/WCLC) ILCN.org (ILCN/WCLC)
twitter youtube facebook linkedin iaslc Home
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
Menu
  • Home
  • Featured Topics
    • Diagnostic Oncology
      • Early Detection & Screening
      • Evolving Standards of Care
      • Global Initiatives
    • Meeting News
      • Names & News
      • Nursing & Allied Health
      • Patient Advocacy
    • Radiation Oncology
      • Regulatory News
      • Risk Assessment and Reduction
      • Society News
    • Supportive & Palliative Care
      • Surgical Oncology
      • Tobacco & Smoking Cessation
      • WCLC News
  • WCLC News
  • About Us
loading...
Home Evolving Standards of Care

A New Standard of Care in EGFR-Positive NSCLC Unresponsive to TKIs?

Myung-Ju Ahn, MD, PhD
on: March 23, 2022In: Evolving Standards of Care
A New Standard of Care in EGFR-Positive NSCLC Unresponsive to TKIs?

Interim analysis from ORIENT-31 demonstrates a four-drug regimen may be a reasonable option for patients whose disease has progressed on EGFR TKIs. Read more


The OncoKB Precision Oncology Knowledge Base: A Q&A with Dr. Debyani Chakravarty

Joy Curzio
on: March 23, 2022In: Evolving Standards of Care
The OncoKB Precision Oncology Knowledge Base: A Q&A with Dr. Debyani Chakravarty

Finding precision treatments after molecular testing requires a tool for reviewing actionable mutations. Read more

Targeting Angiogenesis in Mesothelioma: Insights From MAPS and RAMES

Nirosha D. Perera, MD
+more
on: March 23, 2022In: Evolving Standards of Care
Targeting Angiogenesis in Mesothelioma: Insights From MAPS and RAMES

Without validated biomarkers for anti-angiogenesis therapy, VEGF inhibitors are increasingly being investigated. Read more

US FDA greenlights nivolumab for use before surgery for NSCLC

Erin Jungmeyer
on: March 23, 2022In: Evolving Standards of Care, Industry News & Regulatory Approvals
US FDA greenlights nivolumab for use before surgery for NSCLC

Approval opens the door for an immunotherapy-based treatment option prior to surgery for the first time. Read more

Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Sophie M. Ernst, MD
+more
on: March 09, 2022In: Evolving Standards of Care
Determining the Most Effective Chemotherapy Regimen in Patients With Advanced KRAS-Mutated NSCLC: the NVALT22 study

Study tests combination of taxanes with an angiogenesis inhibitor in search for better outcomes for patients with advanced KRAS-mutated NSCLC. Read more

Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer

Paul Paik, MD
+more
on: March 09, 2022In: Evolving Standards of Care
Novel Targets and Therapies: KEAP1- and NFE2L2-Mutant Squamous Cell Lung Cancer

During an interview with ILCN, Drs. Paul Paik and Jonathan Reiss discuss the implications of KEAP1 and NFE2L2 mutations in NSCLC. Read more

Role of Liquid Biopsy in the Clinic Growing

Leah Lawrence
on: March 09, 2022In: Evolving Standards of Care, Screening/ED
Role of Liquid Biopsy in the Clinic Growing

Lung cancer specialists are slowly being faced with the challenge of how to balance the benefits of next-generation tumor tissue testing against those of liquid biopsy in the clinic. During […] Read more

Multidisciplinary Tumor Boards: Six Eyes See More than Two

Mihaela Aldea, MD, PhD
+more
on: February 23, 2022In: Evolving Standards of Care
Multidisciplinary Tumor Boards: Six Eyes See More than Two

See how specialists in France use MTBs to develop the most beneficial treatment strategies for patients and to decrease inequity in cancer care. Read more

Unplanned Hospital Care in Patients With NSCLC

Manan P. Shah, MD
+more
on: February 23, 2022In: Evolving Standards of Care
Unplanned Hospital Care in Patients With NSCLC

Study findings suggest that a significant number of unplanned hospital visits for patients with lung cancer might be avoidable. Read more

Predicting Early Weight Loss in Radiotherapy

Dirk De Ruysscher, MD, PhD
on: February 23, 2022In: Evolving Standards of Care
Predicting Early Weight Loss in Radiotherapy

Study shows emerging techniques may improve prognostic and predictive models in identifying patients at risk for early weight loss. Read more

‹1234567›»
IASLC Logo
ILCN Editorial Group    IASLC.org   

Advertise with Us   

© 2023 IASLC. All Rights Reserved. Powered By TriStar Event Media, LLC   Privacy Policy